$TGTX News Article - TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum https://marketwirenews.com/news-releases/tg-t...27887.html
My Twitter: WhyteStocks